Plug Power achieves certification for its 1 MW stationary system, marking a milestone for green hydrogen expansion amid strategic business priorities and equipment sales focus.
Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to acquire the exclusive rights for advanced cannabis products. Under the deal, current Remidose customers will be serviced through MediPharm starting August 2024, including Canadian direct-to-patient medical platforms and international medical distributors. MediPharm intends to utilize its existing GMP infrastructure, customer channels and wellness sales expertise to expand the customer base of these advanced products in Canada and internationally.
US Supreme Court upholds 2017 tax on foreign business income, citing Congress' constitutional power to tax. Justices Kavanaugh, Thomas, and Gorsuch dissented.
Darden Restaurants reported Q4 results, and increased its dividend. The company also expects same-restaurant sales growth of 1.0% to 2.0% and new restaurant openings of 45 to 50.